• Rohto Pharmaceutical’s Australian unit Mentholatum Australasia agreed to buy the Pain Away topical pain-relief brand assets from Wellnex Life.
• Deal covers business rights and intellectual property for Pain Away; it is not a share acquisition.
• Pain Away will sit alongside Deep Heat, with plans to drive product, sales, marketing, manufacturing, logistics synergies in Australia.
• Group expects minimal impact on consolidated results for the current fiscal year; targets medium-to-long-term value uplift.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rohto Pharmaceutical Co. Ltd. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.